ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "8406fe61-3b14-425a-91fc-5265344b98f2"}, "_deposit": {"id": "15345", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "15345"}, "status": "published"}, "_oai": {"id": "oai:nagoya.repo.nii.ac.jp:00015345", "sets": ["1446"]}, "item_9_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1979-12", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1-2", "bibliographicPageEnd": "36", "bibliographicPageStart": "27", "bibliographicVolumeNumber": "42", "bibliographic_titles": [{"bibliographic_title": "Nagoya Journal of Medical Science"}]}]}, "item_9_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "To clarify the effect of large dose intratumoral administration of OK-432, experimental and clinical investigations were perfomed. In the experimental study, 250 KE/Kg OK-432 was administered into S-180 sarcoma in ddN mice. Mice treated by OK-432 showed significant increase in delayed hypersensitivity reaction and elongation in the survival times. In the clinical study, 50 KE OK-432 was injected intratumorally during the surgery for the advanced and inoperable malignancy. PHA and PPD skin test reactions, IgG titers, and lymphocyte counts were elevated in the group received the large dose of OK-432. The treatment seemed to contribute to the prolongation of survival times during 3 months after the operation.", "subitem_description_type": "Abstract"}]}, "item_9_identifier_60": {"attribute_name": "URI", "attribute_value_mlt": [{"subitem_identifier_type": "URI", "subitem_identifier_uri": "http://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/4212/4212.html"}, {"subitem_identifier_type": "HDL", "subitem_identifier_uri": "http://hdl.handle.net/2237/17363"}]}, "item_9_identifier_registration": {"attribute_name": "ID登録", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.18999/nagjms.42.1-2.27", "subitem_identifier_reg_type": "JaLC"}]}, "item_9_publisher_32": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Nagoya University School of Medicine"}]}, "item_9_select_15": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_9_source_id_61": {"attribute_name": "ISSN(Online)", "attribute_value_mlt": [{"subitem_source_identifier": "2186-3326", "subitem_source_identifier_type": "ISSN"}]}, "item_9_source_id_7": {"attribute_name": "ISSN(print)", "attribute_value_mlt": [{"subitem_source_identifier": "0027-7622", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "SAKAMOTO, JUNICHI"}], "nameIdentifiers": [{"nameIdentifier": "46761", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "KONDO, TATSUHEI"}], "nameIdentifiers": [{"nameIdentifier": "46762", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "KAMEl, HIDEO"}], "nameIdentifiers": [{"nameIdentifier": "46763", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "ICHlHASHl, HIDEHITO"}], "nameIdentifiers": [{"nameIdentifier": "46764", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "YAMAMURA, YOSHITAKA"}], "nameIdentifiers": [{"nameIdentifier": "46765", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2018-02-20"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "v42n12p27_36.pdf", "filesize": [{"value": "553.4 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 553400.0, "url": {"label": "v42n12p27_36.pdf", "url": "https://nagoya.repo.nii.ac.jp/record/15345/files/v42n12p27_36.pdf"}, "version_id": "1398baf3-4f18-4376-9c20-12b2501f478e"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "The Effect of Large Dose Intratumoral Administration of OK-432 in Advanced Cancer Patients", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "The Effect of Large Dose Intratumoral Administration of OK-432 in Advanced Cancer Patients"}]}, "item_type_id": "9", "owner": "1", "path": ["1446"], "permalink_uri": "https://doi.org/10.18999/nagjms.42.1-2.27", "pubdate": {"attribute_name": "公開日", "attribute_value": "2013-01-23"}, "publish_date": "2013-01-23", "publish_status": "0", "recid": "15345", "relation": {}, "relation_version_is_last": true, "title": ["The Effect of Large Dose Intratumoral Administration of OK-432 in Advanced Cancer Patients"], "weko_shared_id": 3}
  1. C100 医学部/医学系研究科
  2. C100b 紀要
  3. Nagoya journal of medical science
  4. 42(1-2)

The Effect of Large Dose Intratumoral Administration of OK-432 in Advanced Cancer Patients

https://doi.org/10.18999/nagjms.42.1-2.27
https://doi.org/10.18999/nagjms.42.1-2.27
0c5b236e-219f-40cc-8540-180a9876c514
名前 / ファイル ライセンス アクション
v42n12p27_36.pdf v42n12p27_36.pdf (553.4 kB)
Item type 紀要論文 / Departmental Bulletin Paper(1)
公開日 2013-01-23
タイトル
タイトル The Effect of Large Dose Intratumoral Administration of OK-432 in Advanced Cancer Patients
著者 SAKAMOTO, JUNICHI

× SAKAMOTO, JUNICHI

WEKO 46761

SAKAMOTO, JUNICHI

Search repository
KONDO, TATSUHEI

× KONDO, TATSUHEI

WEKO 46762

KONDO, TATSUHEI

Search repository
KAMEl, HIDEO

× KAMEl, HIDEO

WEKO 46763

KAMEl, HIDEO

Search repository
ICHlHASHl, HIDEHITO

× ICHlHASHl, HIDEHITO

WEKO 46764

ICHlHASHl, HIDEHITO

Search repository
YAMAMURA, YOSHITAKA

× YAMAMURA, YOSHITAKA

WEKO 46765

YAMAMURA, YOSHITAKA

Search repository
抄録
内容記述 To clarify the effect of large dose intratumoral administration of OK-432, experimental and clinical investigations were perfomed. In the experimental study, 250 KE/Kg OK-432 was administered into S-180 sarcoma in ddN mice. Mice treated by OK-432 showed significant increase in delayed hypersensitivity reaction and elongation in the survival times. In the clinical study, 50 KE OK-432 was injected intratumorally during the surgery for the advanced and inoperable malignancy. PHA and PPD skin test reactions, IgG titers, and lymphocyte counts were elevated in the group received the large dose of OK-432. The treatment seemed to contribute to the prolongation of survival times during 3 months after the operation.
内容記述タイプ Abstract
出版者
出版者 Nagoya University School of Medicine
言語
言語 eng
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ departmental bulletin paper
ID登録
ID登録 10.18999/nagjms.42.1-2.27
ID登録タイプ JaLC
ISSN(print)
収録物識別子タイプ ISSN
収録物識別子 0027-7622
ISSN(Online)
収録物識別子タイプ ISSN
収録物識別子 2186-3326
書誌情報 Nagoya Journal of Medical Science

巻 42, 号 1-2, p. 27-36, 発行日 1979-12
著者版フラグ
値 publisher
URI
識別子 http://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/4212/4212.html
識別子タイプ URI
URI
識別子 http://hdl.handle.net/2237/17363
識別子タイプ HDL
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 09:16:52.046672
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3